Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study

Ceruloplasmin (Cp) decreases nitric oxide bioavailability in blood and has been associated with cardiovascular disease (CVD) in clinical studies. We assessed the associations between Cp and incident heart failure (HF), death, and CVD in the Atherosclerosis Risk in Communities (ARIC) study. Cp was me...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation. Heart failure 2013-09, Vol.6 (5), p.936-943
Hauptverfasser:	Dadu, Razvan T, Dodge, Rhiannon, Nambi, Vijay, Virani, Salim S, Hoogeveen, Ron C, Smith, Nicholas L, Chen, Fengju, Pankow, James S, Guild, Cameron, Tang, W H Wilson, Boerwinkle, Eric, Hazen, Stanley L, Ballantyne, Christie M
Format:	Artikel
Sprache:	eng
Schlagworte:	African Americans - genetics Aged Atherosclerosis - blood Atherosclerosis - epidemiology Atherosclerosis - ethnology Atherosclerosis - genetics Atherosclerosis - mortality Biomarkers - blood Ceruloplasmin - analysis Ceruloplasmin - genetics Chromosomes, Human, Pair 3 Disease-Free Survival Estrogen Replacement Therapy European Continental Ancestry Group - genetics Female Genetic Predisposition to Disease Genome-Wide Association Study Heart Failure - blood Heart Failure - epidemiology Heart Failure - ethnology Heart Failure - genetics Heart Failure - mortality Humans Incidence Linear Models Male Middle Aged Polymorphism, Single Nucleotide Proportional Hazards Models Prospective Studies Risk Factors Time Factors United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!